Friday, 13 July 2012

Chelsea Therapeutics-Jobs

Chelsea Therapeutics to cut jobs, CEO resigns

(Reuters) - Chelsea Therapeutics International Ltd said it plans to "significantly reduce" its workforce and explore strategic options, barely a week after the U.S. health regulator asked for an additional trial to approve its hypotension drug Northera. The company also said Chief Executive Simon Pedder will step down effective immediately. The job cut is expected to be completed in the third quarter of 2012 and will result in annual salary reductions of at least $3.5 million, excluding any one-time restructuring charges. (Reporting by Esha Dey in Bangalore; Editing by Supriya Kurane) read more..

No comments:

Post a Comment